A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma

A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma

Shuai Zhang, Liya Zhou, Xiaopeng Huang, Shaomin Lin Department of Radiation Oncology, Hainan General Hospital, Haikou 570311, Hainan, China Introduction: The purpose of this study was to analyze the efficacy and safety of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy for N3 stage nasop...

Full description

Bibliographic Details
Main Authors:	Zhang S, Zhou L, Huang X, Lin S
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-06-01
Series:	Cancer Management and Research
Subjects:	Nasopharyngeal carcinoma (NPC) Intensity modulated radiotherapy (IMRT) Chemotherapy S-1 Prognosis
Online Access:	https://www.dovepress.com/a-retrospective-study-of-concurrent-chemoradiotherapy-plus-s-1-adjuvan-peer-reviewed-article-CMAR

Similar Items

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Rui Zou, et al.
Published: (2021-02-01)

Explore the Usefulness of Concurrent Chemotherapy in Stage II Nasopharyngeal Carcinoma: A Retrospective Study
by: Pei-Jing Li, et al.
Published: (2021-09-01)

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study
by: Wen-Ze Qiu, et al.
Published: (2016-01-01)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
by: Jiraporn Setakornnukul, et al.
Published: (2018-03-01)

Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
by: Songthong Anussara, et al.
Published: (2015-06-01)

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
by: Fangfang Kong, et al.
Published: (2018-11-01)

Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD)
by: Ding XC, et al.
Published: (2019-10-01)

Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis
by: Ji-Jin Yao, et al.
Published: (2017-03-01)

Etiology and management of nasopharyngeal hemorrhage after radiotherapy for nasopharyngeal carcinoma
by: Zhan J, et al.
Published: (2019-03-01)

Induction Chemotherapy Combined With Intensity-Modulated Radiotherapy for 129 Nasopharyngeal Carcinoma Patients With Synchronous Metastases: A Retrospective Study
by: Mengshan Ni, et al.
Published: (2021-05-01)

Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis
by: Lei Wang, et al.
Published: (2020-07-01)

Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study
by: Li P, et al.
Published: (2021-09-01)

Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma
by: Sai-Lan Liu, et al.
Published: (2020-11-01)

Dosimetry of Submandibular Glands on Xerostomia for Nasopharyngeal Carcinoma
by: Xin-Bin Pan, et al.
Published: (2021-01-01)

A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma
by: Kaixuan Yang, et al.
Published: (2021-09-01)

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study
by: Yang Li, et al.
Published: (2017-08-01)

The Effect of Prolonged Duration of Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma
by: Yi-Jun Hua, et al.
Published: (2021-09-01)

The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials
by: Yu HL, et al.
Published: (2016-01-01)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
by: Zhen Zeng, et al.
Published: (2018-10-01)

The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
by: Wang Zhi-Qiang, et al.
Published: (2019-11-01)

Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review
by: Wu P, et al.
Published: (2020-02-01)

Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study
by: Lan XW, et al.
Published: (2017-08-01)

Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma
by: Huang JF, et al.
Published: (2017-12-01)

Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy
by: Fen Xue, et al.
Published: (2017-09-01)

Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era
by: Sarbani Ghosh-Laskar, et al.
Published: (2020-03-01)

Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinoma
by: Xue F, et al.
Published: (2017-07-01)

Comparison of Prognosis Between Juvenile and Adult Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis
by: Chen C, et al.
Published: (2020-09-01)

Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy
by: Lertbutsayanukul Chawalit, et al.
Published: (2018-04-01)

Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis
by: Hao Peng, et al.
Published: (2018-03-01)

The Double-Edge Role of the Addition of Adjuvant Chemotherapy to Concurrent Chemoradiotherapy in the Treatment of Nasopharyngeal Carcinoma
by: Liang ZG, et al.
Published: (2020-02-01)

Development and external validation of a nomogram for predicting the overall survival of patients with stage II nasopharyngeal carcinoma after curative treatment
by: He SS, et al.
Published: (2019-05-01)

Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study
by: Luo Y, et al.
Published: (2016-11-01)

Utility of magnetic resonance imaging in determining treatment response and local recurrence in nasopharyngeal carcinoma treated curatively
by: Katherine Meng, et al.
Published: (2020-03-01)

Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study
by: Linger Liu, et al.
Published: (2018-08-01)

Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
by: Cheng Po-Wen, et al.
Published: (2011-08-01)

The effect of adding concurrent chemotherapy to radiotherapy for stage II nasopharyngeal carcinoma with undetectable pretreatment Epstein-Barr virus DNA: Retrospective analysis with a large institutional-based cohort
by: Ya-Nan Jin, et al.
Published: (2021-02-01)

Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma
by: Wei Chen, et al.
Published: (2015-03-01)

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
by: He Y, et al.
Published: (2018-06-01)

Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients
by: Nicola Alessandro Iacovelli, et al.
Published: (2020-09-01)

Sequential induction chemotherapy plus intensity‐modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three‐year report of a phase II, single center, randomized, non‐inferiority trial
by: Zhining Yang, et al.
Published: (2021-06-01)